Prescription Antibiotic Tablets Recalled for Foreign Matter in Active Ingredient
Teva Pharmaceuticals is recalling Neomycin Sulfate Tablets because teflon was found in the active ingredient. Affected lot numbers: 3007830, 3007746, 3007829.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Foreign material contamination in a prescription drug's active pharmaceutical ingredient represents a risk-of-harm product where injury has not yet been reported. No illnesses or injuries have been documented.
Plain-English summary
Teva Pharmaceuticals USA Inc. is recalling Neomycin Sulfate Tablets, USP 500 mg in 100-count bottles because foreign matter identified as teflon was found in the Active Pharmaceutical Ingredient (API) used to manufacture the product. This represents a Current Good Manufacturing Practice (CGMP) deviation.
The recalled medication has lot numbers 3007830, 3007746, and 3007829, with an expiration date of 10/2024. The product was distributed nationwide within the United States.
Patients currently taking this medication from the recalled lots should contact their healthcare provider before discontinuing use. Do not use the product if you have one of the affected lot numbers. Consumers with questions should contact their healthcare provider or the FDA.
The recalled product
- Product
- NEOMYCIN SULFATE (NEOMYCIN SULFATE)
- Brand
- NEOMYCIN SULFATE
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Category
- Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 3007830
- 3007746
- 3007829
- Exp. Date 10/2024
UPCs (1)
- 0300931177018
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · NEOMYCIN SULFATE
- ModerateCardinal Health Recalls Neomycin Sulfate Tablets Due to Storage Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · Teva Pharmaceuticals USA Inc
See all →- SevereOctreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
FDA (Drugs) · 2026-05-13
- ModerateClaravis isotretinoin 10 mg capsules recalled for out-of-specification impurity
FDA (Drugs) · 2026-04-29
- ModerateTeva clonidine 0.2 mg patches recalled over unapproved raw material use
FDA (Drugs) · 2026-04-15
- HighTeva isotretinoin 30 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
- HighTeva isotretinoin 40 mg capsules recalled as superpotent and subpotent
FDA (Drugs) · 2026-04-15
Same hazard · foreign matter
See all →- SevereSpectra Medical Devices Recalls Sodium Chloride Injection Ampules Due to Sterility Concerns
FDA (Devices) · 2026-08-19
- HighLidocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateDivalproex Sodium Delayed-Release Tablets Recalled Due to Presence of Foreign Tablets
FDA (Drugs) · 2026-07-29
- ModeratePasteurized donor human milk bottles show dark spot contamination
FDA (Food) · 2026-06-17
- ModerateVitamin B-Complex and Vitamin C Dietary Supplement Recalled for Foreign Matter
FDA (Food) · 2026-05-27